Congenital heart defects occur in 8 per 1000 live births, with anomalies ranging from minor
septal defects to major structural abnormalities of the great vessels or ventricles. Why focus …

Fetal cardiac intervention (FCI) is a novel and evolving technique that allows for in utero
treatment of a subset of congenital heart disease. This review describes the rationale …

Disclaimer 2020: The EACTS/AEPC Guidelines represent the views of the EACTS and the
AEPC and were produced after careful consideration of the scientific and medical …

Low blood flow through the fetal left heart is often conjectured as an etiology for hypoplastic
left heart syndrome (HLHS). To investigate if a decrease in left heart flow results in growth …

BACKGROUND: Low socioeconomic status (SES) has emerged as an important risk factor
for higher short-term mortality and neurodevelopmental outcomes in children with …

BACKGROUND Children with single ventricle heart disease have significant morbidity and
mortality. The maternal–fetal environment (MFE) may adversely impact outcomes after …

Background: Fetal aortic valvuloplasty (FAV) may prevent progression of midgestation aortic
stenosis to hypoplastic left heart syndrome. However, FAV has well-established risks, and its …

Objective The study objective was to analyze outcomes of the hybrid strategy for ductal-
dependent systemic circulation consisting of bilateral pulmonary artery banding with or …

In hypoplastic left heart syndrome (HLHS), the mechanisms leading to left heart hypoplasia
and their associated fetal abnormalities are largely unknown. Current animal models have …

Objectives To assess health-related quality of life (HRQOL) in families of young children with
complex congenital heart disease (CHD), and identify the demographic, clinical, and …